General
Dosage monitoring of aminoglycosides helps reduce hearing loss in multidrug resistant-TB
 

Dosage monitoring of aminoglycosides helps reduce hearing loss in multidrug resistant-TB

Shared by:

 
Lowering the dosage of aminoglycosides guided by therapeutic dose monitoring (TDM) may reduce aminoglycoside-related hearing loss, without compromising its efficacy against multidrug resistant tuberculosis (MDR-TB), a recent study suggests.
 
specialty.mims.com
 
27 Feb 2017 - General